Source: International Journal of Pharmaceutical Sciences and Research. Unidade: FCFRP
Subjects: RUTÊNIO, CANAIS DE CÁLCIO, FÁRMACOS, VASODILATAÇÃO, DOENÇAS CARDIOVASCULARES
ABNT
NASCIMENTO, Olivia Azevedo et al. Vasorelaxation effect promoted by the calcium channel blocker verapamil coordinated to ruthenium (II): chemical and biological properties. International Journal of Pharmaceutical Sciences and Research, v. 6, n. 9, p. 3733-3743, 2015Tradução . . Disponível em: https://doi.org/10.13040/IJPSR.0975-8232.6(9).3733-43. Acesso em: 31 ago. 2024.APA
Nascimento, O. A., Boffo, E. F., Silva, B. R., Biazzotto, J. C., Bendhack, L. M., Silva, R. S. da, & Lima, R. G. de. (2015). Vasorelaxation effect promoted by the calcium channel blocker verapamil coordinated to ruthenium (II): chemical and biological properties. International Journal of Pharmaceutical Sciences and Research, 6( 9), 3733-3743. doi:10.13040/IJPSR.0975-8232.6(9).3733-43NLM
Nascimento OA, Boffo EF, Silva BR, Biazzotto JC, Bendhack LM, Silva RS da, Lima RG de. Vasorelaxation effect promoted by the calcium channel blocker verapamil coordinated to ruthenium (II): chemical and biological properties [Internet]. International Journal of Pharmaceutical Sciences and Research. 2015 ; 6( 9): 3733-3743.[citado 2024 ago. 31 ] Available from: https://doi.org/10.13040/IJPSR.0975-8232.6(9).3733-43Vancouver
Nascimento OA, Boffo EF, Silva BR, Biazzotto JC, Bendhack LM, Silva RS da, Lima RG de. Vasorelaxation effect promoted by the calcium channel blocker verapamil coordinated to ruthenium (II): chemical and biological properties [Internet]. International Journal of Pharmaceutical Sciences and Research. 2015 ; 6( 9): 3733-3743.[citado 2024 ago. 31 ] Available from: https://doi.org/10.13040/IJPSR.0975-8232.6(9).3733-43